Dr. Elisa Brietzke, MD, PhD
Claim this profileKingston Health Sciences Centre
Affiliated Hospitals
Kingston Health Sciences Centre
Queen's University - Kingston General Hospital
Clinical Trials Elisa Brietzke, MD, PhD is currently running
L-methylfolate
for Generalized Anxiety Disorder
The goal of this feasibility study is to determine the tolerability and safety of add on treatment with L-methylfolate in patients with treatment-resistant generalized anxiety disorder (GAD). The primary objective is to monitor for side effects and other risks associated with the treatment. Secondary objectives are to compare the severity of symptoms, serum levels of folate, vitamin B12, C-reactive protein, homocysteine, tumor necrosis factor alpha and interleukin 6 before and after treatment. Participants will continue with their usual treatment for GAD and receive add on treatment with L-methylfolate 15 mg per day for 8 weeks. All participants will receive the same intervention.
Recruiting
3 awards
Phase 4
Trigeminal Nerve Stimulation
for Generalized Anxiety Disorder
This is a feasibility study for trigeminal nerve stimulation (TNS) in patients with treatment-resistant generalized anxiety disorder (TR-GAD). Ten participants will receive TNS for 8 weeks as an augmentation strategy to pharmacological treatment for generalized anxiety disorder (GAD). * The primary objective is to ascertain if TNS is a safe and well-tolerated treatment for patients with TR-GAD. * The secondary objective will be to monitor changes in GAD symptom severity throughout the study. Results from this study will inform a randomized controlled trial to be conducted in the future.
Recruiting
1 award
N/A
More about Elisa Brietzke, MD, PhD
Clinical Trial Related
1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Elisa Brietzke, MD, PhD has experience with
- Trigeminal Nerve Stimulation
- L-methylfolate
- Ketogenic Diet Therapy
Breakdown of trials Elisa Brietzke, MD, PhD has run
Anxiety
Social Anxiety Disorder
Panic Disorder
Anxiety Disorders
Major Depressive Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elisa Brietzke, MD, PhD specialize in?
Elisa Brietzke, MD, PhD focuses on Anxiety and Social Anxiety Disorder. In particular, much of their work with Anxiety has involved treating patients, or patients who are undergoing treatment.
Is Elisa Brietzke, MD, PhD currently recruiting for clinical trials?
Yes, Elisa Brietzke, MD, PhD is currently recruiting for 2 clinical trials in Kingston Ontario. If you're interested in participating, you should apply.
Are there any treatments that Elisa Brietzke, MD, PhD has studied deeply?
Yes, Elisa Brietzke, MD, PhD has studied treatments such as Trigeminal Nerve Stimulation, L-methylfolate, Ketogenic Diet Therapy.
What is the best way to schedule an appointment with Elisa Brietzke, MD, PhD?
Apply for one of the trials that Elisa Brietzke, MD, PhD is conducting.
What is the office address of Elisa Brietzke, MD, PhD?
The office of Elisa Brietzke, MD, PhD is located at: Kingston Health Sciences Centre, Kingston, Ontario K7L 2V7 Canada. This is the address for their practice at the Kingston Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.